|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 325.70 USD | -6.42% |
|
-1.38% | -7.33% |
| 01/08 | Amgen discloses data breach involving patient health information | RE |
| 31/07 | RBC Cuts Price Target on Stryker to $420 From $435, Keeps Outperform Rating | MT |
Company Valuation: Stryker Corporation
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 1,00,882 | 92,522 | 1,13,776 | 1,37,257 | 1,34,410 | 1,24,930 | - | - |
| Change | - | -8.29% | 22.97% | 20.64% | -2.07% | -7.05% | - | - |
| Enterprise Value (EV) 1 | 1,10,335 | 1,02,451 | 1,21,655 | 1,44,952 | 1,46,258 | 1,33,692 | 1,30,672 | 1,27,325 |
| Change | - | -7.14% | 18.74% | 19.15% | 0.9% | -8.59% | -2.26% | -2.56% |
| P/E | 51.3x | 39.6x | 36.3x | 46.4x | 41.8x | 25.4x | 22.1x | 19.7x |
| PBR | 6.79x | 5.56x | 6.11x | 6.65x | 5.99x | 4.75x | 4.21x | 3.6x |
| PEG | - | 2.1x | 1.1x | -7.81x | 5.07x | 0.5x | 1.5x | 1.6x |
| Capitalization / Revenue | 5.9x | 5.02x | 5.55x | 6.07x | 5.35x | 4.58x | 4.22x | 3.9x |
| EV / Revenue | 6.45x | 5.55x | 5.93x | 6.42x | 5.82x | 4.9x | 4.41x | 3.98x |
| EV / EBITDA | 23.2x | 21.5x | 22.7x | 23.6x | 20.7x | 16.8x | 15.2x | 13.5x |
| EV / EBIT | 25.2x | 23.4x | 24.6x | 25.4x | 22.2x | 18.3x | 16.2x | 14.3x |
| EV / FCF | 40.3x | 50.3x | 39.2x | 41.6x | 34.1x | 34.6x | 26x | 21.9x |
| FCF Yield | 2.48% | 1.99% | 2.55% | 2.41% | 2.93% | 2.89% | 3.85% | 4.57% |
| Dividend per Share 2 | 2.585 | 2.835 | 3.05 | 3.24 | 3.4 | 3.632 | 3.826 | 4.11 |
| Rate of return | 0.97% | 1.16% | 1.02% | 0.9% | 0.97% | 1.12% | 1.17% | 1.26% |
| EPS 2 | 5.21 | 6.17 | 8.25 | 7.76 | 8.4 | 12.82 | 14.71 | 16.53 |
| Distribution rate | 49.6% | 45.9% | 37% | 41.8% | 40.5% | 28.3% | 26% | 24.9% |
| Net sales 1 | 17,108 | 18,449 | 20,498 | 22,595 | 25,116 | 27,290 | 29,599 | 32,001 |
| EBITDA 1 | 4,753 | 4,755 | 5,348 | 6,142 | 7,064 | 7,967 | 8,586 | 9,454 |
| EBIT 1 | 4,382 | 4,384 | 4,955 | 5,715 | 6,603 | 7,293 | 8,055 | 8,890 |
| Net income 1 | 1,994 | 2,358 | 3,165 | 2,993 | 3,246 | 4,896 | 5,568 | 6,536 |
| Net Debt 1 | 9,453 | 9,929 | 7,879 | 7,695 | 11,848 | 8,762 | 5,742 | 2,395 |
| Reference price 2 | 267.42 | 244.49 | 299.46 | 360.05 | 351.47 | 325.70 | 325.70 | 325.70 |
| Nbr of stocks (in thousands) | 3,77,240 | 3,78,430 | 3,79,938 | 3,81,216 | 3,82,424 | 3,83,573 | - | - |
| Announcement Date | 27/01/22 | 31/01/23 | 30/01/24 | 28/01/25 | 29/01/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 25.4x | 4.9x | 16.78x | 1.12% | 12TCr | |
| 19.33x | 2.44x | 9.4x | 2.65% | 1.31TCr | |
| -206.11x | 13.98x | 1659.13x | -.--% | 982.91Cr | |
| 24.54x | 11.5x | 19.31x | 1.77% | 486.4Cr | |
| 25.87x | - | - | - | 261.42Cr | |
| 242.92x | 1.23x | 6.71x | -.--% | 167.79Cr | |
| 17.96x | 4.87x | 9.51x | 3.41% | 167.18Cr | |
| 130.04x | 1.4x | 6.92x | -.--% | 144.67Cr | |
| Average | 34.99x | 5.76x | 246.82x | 1.28% | 2TCr | |
| Weighted average by Cap. | 13.82x | 5.39x | 118.44x | 1.2% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- SYK Stock
- Valuation Stryker Corporation
Select your edition
All financial news and data tailored to specific country editions
